ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,784, issued on Jan. 20, was assigned to Chia Tai Tianqing Pharmaceutical Group Co. Ltd. and (Lianyungang, China) and Nanjing Shunxin Pharmaceuticals Co. Ltd. Of Chiatai Tianqing Pharmaceutical Group (Nanjing, China).

"Combined pharmaceutical composition for treating small cell lung cancer" was invented by Shanchun Wang (Lianyungang, China), Xunqiang Wang (Lianyungang, China), Ding Yu (Lianyungang, China), Wenwen Liu (Lianyungang, China), Chao Shu (Lianyungang, China) and Mengxue Fan (Lianyungang, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the field of biomedicine and relates to a combined pharmaceutical com...